ArticleStatistics in medicine2026
Testing and Quantifying Site-Level Variability in Diagnostic Sensitivity of an Anchor Variable.
Article in Statistics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
In multi-site clinical research, diagnostic assessments can vary across sites even when standardized criteria and instruments are used, leading to inconsistent disease classification. This issue is examined in settings with an anchor variable that confidently identifies disease when positive but provides no information when negative. A random effects model is introduced for site-specific sensitivity, along with likelihood-based methods for estimation and hypothesis testing. The approach addresses two objectives: testing whether diagnostic sensitivity varies across sites, and quantifying the magnitude of such variability. Validation data is incorporated to establish parameter identifiability. Laplace approximation and the Expectation-Maximization (EM) algorithm are further engaged to address the computational challenge caused by an intractable integral in the likelihood function. Likelihood ratio and score tests are constructed to account for the boundary constraint that arises when the null hypothesis places the variance component at zero. Simulation studies demonstrate the good performance in finite samples, with accurate parameter estimates and appropriate test size and power. Application to a multi-site Huntington disease cohort for diagnosing mild cognitive impairment reveals differences in diagnostic sensitivity across sites, with tests providing strong evidence of heterogeneity. This framework offers a principled approach for testing and quantifying site-level variability in diagnostic sensitivity, supporting more consistent inference in multi-site studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.